首页> 美国卫生研究院文献>RMD Open >Original article: Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

【2h】

Original article: Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

机译：原始文章：血清骨桥蛋白：巨细胞性动脉炎患者疾病活动的生物标志物和复发过程的预测因子。托珠单抗治疗的患者的潜在临床价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundOsteopontin (OPN) is a glycoprotein involved in Th1 and Th17 differentiation, tissue inflammation and remodelling. We explored the role of serum OPN (sOPN) as a biomarker in patients with giant cell arteritis (GCA).

机译：背景骨桥蛋白（OPN）是一种糖蛋白，参与Th1和Th17分化，组织炎症和重塑。我们探讨了血清OPN（sOPN）作为巨细胞性动脉炎（GCA）患者的生物标志物的作用。

著录项

期刊名称 RMD Open
作者
Sergio Prieto-González; Nekane Terrades-García; Marc Corbera-Bellalta; Ester Planas-Rigol; Chie Miyabe; Marco A Alba; Ariel Ponce; Itziar Tavera-Bahillo; Giuseppe Murgia; Georgina Espígol-Frigolé; Javier Marco-Hernández; José Hernández-Rodríguez; Ana García-Martínez; Sebastian H Unizony; Maria C Cid;
展开▼
作者单位

展开▼
年(卷),期 2012(3),2
年度 2012
页码 e000570
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
giant cell arteritis, corticosteroids, cytokines, systemic vasculitis;

机译：巨细胞动脉炎;皮质类固醇;细胞因子;系统性血管炎;
入库时间 2022-08-17 12:47:54

相似文献

外文文献
中文文献
专利

1. Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients [J] . Nekane Terrades-García, Marc Corbera-Bellalta, Ester Planas-Rigol, RMD Open . 2017,第2期

机译：血清骨桥蛋白：巨细胞性动脉炎患者疾病活动的生物标志物和复发过程的预测因子。托珠单抗治疗的患者的潜在临床价值
2. Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity [J] . Oraby Mohammed I., El Masry Hatem A., Abd El Shafy Sanaa S., The Egyptian Journal of Neurology, Psychiatry and Neurosurgery . 2021,第a期

机译：血清脑衍生的神经营养因子患者复发 - 重复多发性硬化症：疾病活动的潜在生物标志物
3. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib [J] . Cho Hyo Jung, Kim Soon Sun, Nam Ji Sun, Cytokine . 2017,第期

机译：更高的血清白细胞介素-17a水平作为潜在的生物标志物，用于预测乙型肝炎病毒相关晚期肝细胞癌患者早期疾病进展的潜在生物标志物
4. Serum diagnostics and clinical value of anti-thyroid autoantibodies of different specificity and functionality in patients with autoimmune thyroid diseases and their relatives as disease predictors [C] . Andreeva A.V., Bogatyreva Z.I., Isaeva M.A., World Asthma and COPD Forum . 2010

机译：自身免疫甲状腺疾病患者及其亲属作为疾病预测因子的患者抗甲状腺自身抗体的抗甲状腺自身抗体的临床价值
5. Serum and Fecal Biomarkers Predict Response to Infliximab Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Kim, Jochebed. 2020

机译：血清和粪便生物标志物预测对炎症肠病小儿患者的英夫利昔单抗疗法的反应
6. Original research article: Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI) [O] . Matthias Lutz, Nora von Ingersleben, Moritz Lambers, 2017

机译：原始研究文章：骨桥蛋白预测经导管主动脉瓣植入术（TAVI）治疗严重主动脉瓣狭窄后的患者临床结果
7. Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients [O] . Sergio Prieto-González, Nekane Terrades-García, Marc Corbera-Bellalta, 2017

机译：血清骨桥蛋白：巨型细胞动脉炎患者疾病活动的生物标志物和复发过程中的预测。托运毒液治疗患者的潜在临床有用

Original article: Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

摘要

著录项

相似文献

相关主题

期刊订阅